Conor Medsystems, Biotronik DES Would Compete With Established Players

Conor Medsystems expects technological characteristics - not price - will successfully position its CoStar drug-eluting stent against offerings from Johnson & Johnson and Boston Scientific

More from Archive

More from Medtech Insight